Waterdrop Inc.

Waterdrop Inc.

NNYSE:WDH
1.00
USD
-0.01
(-0.99%)
0.22EPS
5.07P/E
406.01MMarket Cap
Dec 09Next Earn

Q1 FY2026 · Earnings Call TranscriptJune 16, 2026

Tracy Li

Good morning, everyone. This is Tracy Li from Waterdrop Investor Relations.

It's my pleasure to welcome everyone to Waterdrop's first quarter 2026 earnings conference call. All participants are in listen-only mode in our English line.

As a reminder, today's conference call is being recorded. Please note that discussion today will contain forward-looking statements made under the safe harbor provisions of the U.S.

Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from our current expectations.

Potential risks and uncertainties include, but not limited to, those outlined in our public filings with the SEC. The company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Also, this call includes discussion of certain non-GAAP measures. Please refer to our earnings release for reconciliations between non-GAAP and GAAP.

Joining us today on the call are Mr. Shen Peng, our Founder, Chairman and CEO; Mr.

Ran Wei, Director and GM of Insurance Business; Ms. Xu Xiaoying, Head of Finance Department; and Ms.

Li Jieru, Board Secretary. We will take questions in the Mandarin line at the end of the conference call.

Now let's invite our CEO Shen Peng to start.

Shen Peng

Dear investors and analysts, thank you for joining Waterdrop's first quarter 2026 earnings conference call. In the first quarter, we continued our last year's growth momentum, with total revenue of 1.24 billion yuan, up 64.8% year-over-year, and net profit attributable to ordinary shareholders of more than 98 million yuan.

Since the first quarter of 2022, we have maintained GAAP profitability for 17 consecutive quarters. By segment, our insurance business continued its user acquisition strategy, with insurance-related income up 74.1% year-over-year.

As this capability has been validated, we shifted our focus on user experience, while continuing to optimize our traffic channels and user targeting efficiency. The crowdfunding business remained stable, having raised medical funds for cumulative 3.75 million patients by the end of the Q1.

Our digital clinical trial solutions business sustained enrollment growth, with more than 15,500 patients enrolled to date. On technology front, we are accelerating our shift toward an AI-native company.

As of March 31st, 2026, we had filed 75 LLM-related patent applications, including nine international ones, and were recently granted two more national invention patents in intelligent semantic understanding and multimodal recommendation. These technologies will be progressively applied to the insurance scenarios, such as intelligent customer service and claims, improving service quality and efficiency.

On capital returns, we continue to share our growth with our shareholders. In early May, we completed our fifth cash dividend since our IPO, totaling approximately $10.8 million.

Our share repurchase program also continued steadily. By the end of May 2026, we had repurchased approximately 61.8 million ADSs in open market for about $120 million.

As of the end of May 2026, cumulative cash dividends and share repurchases since IPO had totaled approximately $170 million. Meanwhile, we remain committed to giving back to society.

As of the end of the Q1, the Waterdrop charity platform had partnered with 119 public charitable organizations and launched over 15,500 charity programs. Looking ahead, we aim to seize industry opportunities and make growth our top priority this year.

Building on our proven user targeting capabilities, we will be increasing marketing investment further. For 2026, we are targeting approximately 40% top-line growth, with operating profit scale is expected to remain largely stable.

We expect this current investment to unlock greater profit potential in the coming years, and the user base expansion will further support the company's long-term development. That covers our overall performance in Q1.

Next, I will walk through each of our business segments in detail.

Wei Ran

Hello, everyone. This is Ran Wei.

Let me walk you through the progress of the insurance business. In the first quarter, insurance-related income reached 1.15 billion, up 74.1% year-over-year, with operating profit of 150 million yuan.

Operating margin is of Q1 is 13.3%. The year-over-year top-line growth mainly reflects the continuation of our last year, our last year user acquisition strategy.

In the first quarter, we continued to step up public domain user targeting and increasingly, increased our investment in traffic and AI, driving significant premium, premium growth. On a quarter-over-quarter basis, while the income declined, our insurance operating margin rose by 2 percentage points.

This was mainly because we proactively cut some lower-ROI channels during this quarter. At the same time, we are actively expanding into other high-quality traffic channels, while running our mature ones with refined operations, enhancing our traffic infrastructure, and optimizing our models to drive continue improvement in ROI.

On the supply side, we are committed to giving users more diverse offering, offerings, product offerings, which continued to earn user recognition. During this quarter, FYP for from our pre-existing condition products rose 24.3% year-over-year, and the disability insurance products contributed 89 million in FYP.

At the product level, we continued to iterate. For example, we upgraded our inclusive cancer worry-free medical insurance series, expanding the coverage for out-of-the-hospital prescriptions and related medical devices, devices, as well as a range of advanced cancer therapies.

We also recently launched the Shouhuzhu-focused cancer-specific product with a simpler health disclosure and lower the bar to lifelong cancer protection. On the service side, service side, we took multiple steps to improve the customer experience.

We launched a dedicated customer complaint hotline to make it easier for users to raise their concerns, and we also connected payment channels with our customer service system, expanding frontline authorization and enable faster refund processing. For elderly customers, we simplified procedures for their children acting on their behalf, and introduced a fast-track service channel.

Together, this initiative, initiatives upgraded our after-sales service capability. We also continued to apply our LLM capabilities and AI tools to streamline, streamline workflows and improve operating efficiency.

The user-facing AI applications continued approximately, contributed approximately 87 million yuan in incremental premiums in Q1, up 17.7% sequentially. Through real-time support on our mini-programs, WeChat, phone calls, and WeCom, including our AI Pro Insurance and AI Medical Insurance experts, WeCom AI, and other tools.

For our frontline consultants, Kuaiyi AI had handled more than 10,000 underwriting inquiries to date. In late March, we began internal beta testing of the Claude, Claude CoPilot on CRM and WeCom, bringing together our product knowledge base, Kuaiyi AI, and other two agent tools, our consultants can get instant answers on products, underwriting, and other common questions, with less switching between the systems and documents.

Claude CoPilot also supports the self, the user review, talk tracks replay and refinement, and performance analysis. In after-sales service, our AI user service agents are now in regular operation, support more than 1 million service interaction per month.

The AI service quality copilot continued to deliver efficiency of more than twice the manual-only basis, this baseline. On the AI infrastructure side, our low-code platform Waterdrop B.AI now offers more than 30 purpose-built agents, each tailored to a specific scenario for our internal team and external clients in all the user-facing work.

That concluded our insurance business update for the first quarter.

Yao Hu

Thank you, Ran Wei. This is Jieru, and next I will walk you through our first quarter performance on our crowdfunding and healthcare businesses.

As of the end of March 2026, approximately 494 million people had cumulatively donated a total of 73.5 billion to one to 3.75 million patients through the Waterdrop medical crowdfunding platform. This quarter, we pursued two priorities for Waterdrop medical crowdfunding: the AI capability building and better service in linguistically diverse regions.

For AI review, we completed an quarterly upgrade, evolving toward an AI-assisted model without compromising risk control quality. Our risk model can structure the campaign material quickly and applied the preset rules for preliminary screening, shorten intake and the first-pass review and free our risk specialists for complex cases.

Secondly, we improved the service for patients in linguistically diverse communities, including areas where a minority language are widely spoken. In this quarter, we systematically refined our service workflows and adapted the review standard to their real needs.

We added minority language specialists to work alongside our existing campaign consultants on upfront consultation, and the document guidance, and the dispute resolution, and reducing the communication cost caused by language barriers. In addition, we set up a dedicated service team in which the consultant and the risk control specialist can track each case end-to-end and promptly resolve the bottleneck, ensuring a strict risk control compliance while respecting local culture sensitivities.

Turning to our healthcare business, we sustained high-quality growth this quarter, broaden LLM application across core business scenarios. We partnered with 243 pharmaceutical companies and CROs, and initiated services for 128 new programs.

Our E-Find platform single-quarter patient enrollment rose 16% year-over-year, and newly signed project in this quarter increased 53%, reflecting the wider partnership coverage and the deeper client engagement. As of the end of the first quarter of 2026, the platform had cumulatively enrolled over 15,500 patients.

In January 2026, our intelligent trial patient matching technology secured a national invention patent, which is the first of this kind in China. This quarter, we focused on building out our upstream data structuring capabilities and connecting it with the matching engine.

Across part of our service workflow, the platform has now established a standardized pipeline from the data structuring to intelligent project matching, promptly generating suitability recommendation against the trial protocol. Supported by this AI capabilities, we continued to build our medical case library in complex indications and rare cancers, with a more balanced mix across therapeutic areas, strengthening the foundation for sustainable mid-term to long-term growth.

That covers our crowdfunding and healthcare businesses.

Xiaoying Xu

Hello, everyone. This is Xu Xiaoying.

I will now walk through our financial highlights for the first quarter of 2026. Before I go into details, please be reminded that all numbers quoted here will be in RMB, and please refer to our earnings release for detailed information on our financial performance on both year-over-year and quarter-over-quarter basis, respectively.

In the first quarter of 2026, Waterdrop's total revenue reached 1.24 billion, up 64.8% year-over-year, sustaining rapid growth. By segment, the insurance-related income contributed approximately 1.15 billion, up 74.1% year-over-year, while the non-insurance business together accounted for about 7.8% of total revenue, with crowdfunding service fees of approximately 60.73 million and digital clinical trial solution income of approximately 24.2 million.

Turning to costs, our total operating costs and expenses for this first quarter were approximately 1.16 billion, up about 71.5% year-over-year. Operating costs for this quarter reached 487 million, up 30.1% year-over-year, driven by our business expansion.

Cost of referral services increased by about 53.9 million, while short message service costs and personal costs rose by 38.9 million and 7.3 million, respectively. Sales and marketing expenses reached 541 million, a significantly increase from 172 million in the same period last year, mainly because we progressively scaled up traffic investment over the past year and reinforced growth momentum.

Marketing expenses for third-party traffic channels rose by approximately 361 million year-over-year. General and administrative expenses were 71.7 million, down 4.3% year-over-year, mainly due to the lower professional service fees this quarter.

Research and development expenses were about 62.7 million, an 11.5% year-over-year increase, primarily due to an approximately 6.7 million rise in cloud and technical service fees. For the quarter, for the first quarter, operating profit was around 79.95 million, a modest year-over-year increase of 5.3%.

However, affected by the non-operating items in this quarter, the net profit attributable to ordinary shareholders was approximately 98.4 million, down 9.1% year-over-year. As of the end of March 2026, the company maintained an ample cash, ample cash reserve, with cash and cash equivalents, short-term investments, and other cash position totaled about approximately 2.88 million, 2.88 billion.

On capital returns, since our IPO through May 1st, 2026, we we repurchased, cumulatively repurchased a total of approximately 61.8 million ADSs for about $120 million, and recently completed cash dividend of approximately $10.8 million. Overall, the growth momentum of our core business remained strong, and in first quarter, Waterdrop delivered 64.8% year-over-year revenue growth.

By stepping up the investment in traffic and AI, continues to strengthen our long-term competitiveness. Ladies and gentlemen, with that we will conclude today's conference call.

We do thank you for joining. Have a good time.